Sarissa Capital Management LP Cytokinetics Inc Transaction History
Sarissa Capital Management LP
- $592 Million
- Q2 2024
A detailed history of Sarissa Capital Management LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Sarissa Capital Management LP holds 1,110,000 shares of CYTK stock, worth $57.5 Million. This represents 10.15% of its overall portfolio holdings.
Number of Shares
1,110,000
Previous 300,000
270.0%
Holding current value
$57.5 Million
Previous $21 Million
185.93%
% of portfolio
10.15%
Previous 3.68%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$760 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$593 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$422 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$389 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$339 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.88B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...